ALTIMMUNE INC News (NASDAQ:ALT)

Add to My Stocks
$4.89 $0.56 (10.28%) ALT stock closing price Sep 17, 2018 (Closing)
Altimmune Restructures Financing Agreement   by Globe Newswire on Jun 22, 2018

ALT Industry Peers

Company Price Change (%)
Relmada Therapeutics (RLMD)0.950 (0%)
Ohr Pharmaceuticals (OHRP)0.190.01 (5.56%)
Sonoma Pharmact (SNOA)1.50.01 (0.66%)
Protalex (PRTX)0.160.04 (20%)
Ibio (IBIO)0.860.01 (1.18%)
Soligenix (SNGX)1.480.01 (0.67%)
Merck (MRK)70.420.44 (0.63%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Catasys (CATS)12.441.93 (18.36%)
Concord Medical Services (CCM)3.4990.48 (15.92%)
Opko Health (OPK)4.4850.59 (15.13%)
FutureFuel (FF)17.972.11 (13.3%)
Grupo Financiero Galicia (GGAL)23.632.23 (10.42%)
Neptune Tech. & Bio. (NEPT)4.210.39 (10.21%)
Frontier Communications (FTR)6.380.59 (10.19%)
Top gainers from NASDAQ & NYSE ( Above $100M Market Cap )
* As of Sep 18, 2018
CompanyPriceChange (%)
Swiss Helvetia Fund (SWZ)8.614.78 (35.7%)
Radcom (RDCM)12.255 (28.99%)
Government Properties Income Trust (GOV)12.6954.2 (24.87%)
Renren (RENN)1.540.29 (15.85%)
Tandem Diabetes Care (TNDM)40.187.45 (15.64%)
Maiden (MHLD)2.650.45 (14.52%)
TG Therapeutics (TGTX)9.51.25 (11.63%)
Top losers from NASDAQ & NYSE ( Above $100M Market Cap )
* As of Sep 18, 2018